ロード中...
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
BACKGROUND/AIM: Patients with HBV-related decompensated cirrhosis (HBV-DeCi) should be treated with potent nucleos(t)ide analogues (NA)[entecavir (ETV) or tenofovir (TDF)]. The aim was the evaluation of safety and efficacy in terms of changes in liver disease course in HBV-DeCi patients treated with...
保存先:
| 出版年: | Ann Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hellenic Society of Gastroenterology
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289983/ https://ncbi.nlm.nih.gov/pubmed/25608681 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|